Literature DB >> 26355712

Size-dependent specific targeting and efficient gene silencing in peritoneal macrophages using a pH-sensitive cationic liposomal siRNA carrier.

Hideki Matsui1, Yusuke Sato1, Hiroto Hatakeyama1, Hidetaka Akita1, Hideyoshi Harashima2.   

Abstract

Macrophages are key contributors to various inflammatory diseases. Therefore, the development of an efficient in vivo short interference RNA (siRNA) system that can be delivered to macrophages represents a novel treatment strategy for addressing these disorders. It was recently revealed that peritoneal macrophages (PEMs) are involved in several diseases including ovarian cancer, and are now recognized as a promising drug target. We report herein on the use of pH-sensitive cationic YSK05-MENDs as siRNA carriers and on the impact of both the size of the YSK05-MENDs and their administration routes for the efficient targeting PEMs to achieve a high level of gene silencing activity. The size of the YSK05-MENDs had a dramatic effect on their specificity for PEMs when administered intravenously, but not for intraperitoneal injection. Also, significant gene silencing was achieved by an intraperitoneal administration of the YSK05-MEND at a dose in the single digit μg/kg range. To our knowledge, this is the most efficacious method for siRNA delivery for gene silencing in PEMs in vivo reported to date. These findings enabled us to investigate the complex function of PEMs through several gene silencing simultaneously.
Copyright © 2015 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Administration route; Multifunctional envelope-type nano device; Peritoneal macrophages; Short interference RNA; Size; pH-Sensitive cationic lipid

Mesh:

Substances:

Year:  2015        PMID: 26355712     DOI: 10.1016/j.ijpharm.2015.08.044

Source DB:  PubMed          Journal:  Int J Pharm        ISSN: 0378-5173            Impact factor:   5.875


  3 in total

1.  Mixing lipids to manipulate the ionization status of lipid nanoparticles for specific tissue targeting.

Authors:  Nour Shobaki; Yusuke Sato; Hideyoshi Harashima
Journal:  Int J Nanomedicine       Date:  2018-12-10

Review 2.  Imaging and therapy of ovarian cancer: clinical application of nanoparticles and future perspectives.

Authors:  Giovanni Di Lorenzo; Giuseppe Ricci; Giovanni Maria Severini; Federico Romano; Stefania Biffi
Journal:  Theranostics       Date:  2018-07-30       Impact factor: 11.556

Review 3.  Advances in Lipid Nanoparticles for mRNA-Based Cancer Immunotherapy.

Authors:  Maria L Guevara; Francesca Persano; Stefano Persano
Journal:  Front Chem       Date:  2020-10-23       Impact factor: 5.221

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.